Mobenol
Brand names,
Mobenol
Analogs
Mobenol
Brand Names Mixture
Mobenol
Chemical_Formula
C12H18N2O3S
Mobenol
RX_link
No information avaliable
Mobenol
fda sheet
Mobenol
msds (material safety sheet)
Mobenol
Synthesis Reference
No information avaliable
Mobenol
Molecular Weight
270.349 g/mol
Mobenol
Melting Point
128.5 oC
Mobenol
H2O Solubility
109 mg/L
Mobenol
State
Solid
Mobenol
LogP
2.765
Mobenol
Dosage Forms
Tablet (250 and 500 mg)
Mobenol
Indication
Used as an oral hypoglycemic agent in non-insulin-dependent (type 2) Diabetes Miletus with adult onset.
Mobenol
Pharmacology
Tolbutamide, a second-generation sulfonylurea antidiabetic agent, is used with diet to lower blood glucose levels in patients with diabetes mellitus type II. Tolbutamide is twice as potent as the related second-generation agent glipizide. Tolbutamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must be able to produce insulin for this drug to work.
Mobenol
Absorption
Well absorbed. Absorption is unaltered if taken with food but is increased with high pH.
Mobenol
side effects and Toxicity
Oral, mouse: LD50 = 2600 mg/kg
Mobenol
Patient Information
Treatment with tolbutamide may increase the risk of death from cardiovascular disease compared to treatment of diabetes with diet alone or diet plus insulin. Discuss with your doctor the risks and benefits of treatment with tolbutamide. Know the signs and symptoms of low blood sugar (hypoglycemia), which include headache, drowsiness, weakness, dizziness, fast heartbeat, sweating, tremor, and nausea. Carry a piece of hard candy or glucose tablets with you to treat episodes of low blood sugar. Follow your diet, medication, and exercise routines closely. Changing any of them can affect blood sugar levels. Do not change your dose of tolbutamide without first talking to your doctor. Avoid alcohol. It lowers blood sugar and may interfere with your diabetes treatment.
Mobenol
Organisms Affected
Humans and other mammals